Kidney Transplants and HIV: What the Numbers Show

People living with HIV often face a higher chance of their new kidney being rejected, yet scientists have not fully figured out why. One theory points to the hidden HIV viruses that linger in the body, called the latent viral reservoir (LVR). These dormant copies could disrupt the immune system and spark inflammation, potentially leading to rejection.

Study Design

• Participants: Kidney transplant patients with HIV.
• Duration: 52 weeks (one year).
• Measurements: Size of the LVR at baseline and after 52 weeks using a specialized DNA test that detects intact viral copies.
• Groups:
• Patients who received kidneys from HIV‑positive donors.
• Patients who received kidneys from HIV‑negative donors.

Key Findings

The amount of hidden virus did not differ between patients whose kidneys were rejected and those who kept their transplants, regardless of donor HIV status.

Implications

• Dormant HIV is unlikely to be a major factor in transplant rejection.
• Supports the safety of kidney sharing between people with HIV, expanding options for patients needing a new organ.

Study Context

• Part of a larger clinical trial (NCT03500315).
• Adds valuable data to the conversation about optimal support for people with HIV requiring kidney transplants.